CAL
CABA icon

Capital Advisors Ltd’s Cabaletta Bio CABA Stock Holding History

Capital Advisors Ltd’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-81
Closed – – 1361
2024
Q4 		$0 Hold
81
– – ﹤0.01% 1388
2024
Q3 		$0 Hold
81
– – ﹤0.01% 1393
2024
Q2 		$1K Hold
81
– – ﹤0.01% 1138
2024
Q1 		$1K Hold
81
– – ﹤0.01% 1134
2023
Q4 		$2K Hold
81
– – ﹤0.01% 993
2023
Q3 		$1K Hold
81
– – ﹤0.01% 1088
2023
Q2 		$1K Hold
81
– – ﹤0.01% 1099
2023
Q1 		$1K Hold
81
– – ﹤0.01% 996
2022
Q4 		$1K Buy
+81
New +$295 ﹤0.01% 957

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Advisors Ltd's CABA Position: Q1 2025 in Review

Capital Advisors Ltd sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 81 shares.

Capital Advisors Ltd first reported a position in CABA in Q4 2022 and held it in 9 quarters. The position peaked at $2K in Q4 2023. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Capital Advisors Ltd reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 81 Cabaletta Bio shares in Q1 2025.
  • Capital Advisors Ltd first reported a position in Cabaletta Bio in Q4 2022 and held it in 9 quarters.
  • Capital Advisors Ltd's Cabaletta Bio position peaked at $2K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Capital Advisors Ltd's 13F filing for Q1 2025, filed 15 Apr 2025.